Kirkland & Ellis advised Aleph Capital Partners and Crestview Partners on the transaction. Aleph Capital Partners and Crestview Partners, leading private equity firms based in London...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented VMG Partners and [solidcore] in the transaction, and Kirkland & Ellis represented L Catterton. L Catterton announced it has signed a definitive...
You must be a Standard 1 Year member to access this content.
Goodwin advised SpringWorks Therapeutics, Inc. on the offering. American precision medicine company SpringWorks Therapeutics (Nasdaq: SWTX) has closed a public offering of 10,905,171 shares of its common...
You must be a Standard 1 Year member to access this content.
Kyowa Kirin was represented by Goldman Sachs Japan Co., Ltd. as financial advisor and Morrison & Foerster LLP. as legal advisor. Orchard Therapeutics was represented by...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis served as legal advisor to Express on the transaction, and Goodwin Procter served as legal advisor to WHP Global. Express, Inc. (NYSE: EXPR) and WHP...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised WHP Global on the deal, while Kirkland & Ellis advised Express. WHP Global entered into a mutually transformative strategic partnership with Express, Inc. (NYSE:...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Navitor Pharmaceuticals on the deal. Privately held Navitor Pharmaceuticals, LLC (“Navitor”), announced that Janssen Pharmaceuticals, Inc. (“Janssen”), one of the Janssen Pharmaceutical Companies...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Eluminex Biosciences on the deal. Eluminex Biosciences (Suzhou) Limited (Eluminex) announced its acquisition of certain assets and the related global development and commercialization rights...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr advised the underwriters on the deal while Goodwin Procter represented Amylyx Pharmaceuticals. Amylyx Pharmaceuticals, Inc. (“Amylyx”), a clinical-stage pharmaceutical company...
You must be a Standard 1 Year member to access this content.
Cooley LLP advised Exscientia on the deal while Goodwin Procter represented Goldman Sachs & Co. LLC, Morgan Stanley & Co. LLC, BofA Securities and Barclays Capital...
You must be a Standard 1 Year member to access this content.
Goodwin Procter and Baker McKenzie advised Trillium Therapeutics on the deal, while Ropes & Gray LLP and Norton Rose Fulbright Canada represented Pfizer. Trillium Therapeutics (NASDAQ/TSX:...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised the underwriters on the deal, while Dechert advised Femasys. Chardan, a global investment bank, announced that it acted as lead left bookrunner in...
You must be a Standard 1 Year member to access this content.
